EuBiologics Co., Ltd. (KOSDAQ: 206650)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,130
-450 (-3.58%)
Dec 19, 2024, 9:00 AM KST

EuBiologics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
433,662418,137324,3591,271,414655,399
Market Cap Growth
28.91%28.91%-74.49%93.99%-
Enterprise Value
430,394418,132320,5501,239,111-
Last Close Price
11870.0011470.008900.0035050.0021300.00
PS Ratio
6.246.035.8532.2823.00
PB Ratio
3.893.992.7210.846.77
P/TBV Ratio
3.883.882.6610.756.87
P/FCF Ratio
22.2221.43---
P/OCF Ratio
15.8115.8150.37-395.02
EV/Sales Ratio
6.206.035.7831.46-
EV/EBITDA Ratio
26.3224.7977.93--
EV/EBIT Ratio
59.8954.31---
EV/FCF Ratio
22.0521.43---
Debt / Equity Ratio
0.140.140.130.130.23
Debt / EBITDA Ratio
0.880.883.81--
Debt / FCF Ratio
0.760.76---
Asset Turnover
0.440.440.350.26-
Inventory Turnover
2.262.261.952.01-
Quick Ratio
0.770.770.591.991.65
Current Ratio
1.631.631.673.112.03
Return on Equity (ROE)
-13.70%-13.70%-2.90%-26.17%-
Return on Assets (ROA)
3.07%3.07%-1.51%-2.95%-
Return on Capital (ROIC)
3.78%3.78%-1.76%-3.58%-
Earnings Yield
-3.21%-3.32%-0.34%-2.17%-9.18%
FCF Yield
4.50%4.67%-0.81%-1.12%-0.97%
Buyback Yield / Dilution
-0.13%-0.13%-2.68%-26.53%-
Total Shareholder Return
-0.13%-0.13%-2.68%-26.53%-
Source: S&P Capital IQ. Standard template. Financial Sources.